Back to Selection     Print       Date : 31 Oct 2025
Fund Summary
ITI Pharma and Healthcare Fund Reg (G)
[Equity: Sectoral]  
 
Fund Details
Fund Type Growth Launch Date 08-Nov-21
Corpus(Cr.) 226.0 Latest NAV 16.0304 As on 05-12-2025
Equity(%) 98.31 52 Week High 17.6024
Debt(%) 1.69 52 Week Low 14.552
Others(%) 0.0 Exit Load 0.5% for redemption within 3 months
Minimum Investment - Availability
Entry Load Nil Expense Ratio(%) 2.35
Scheme Benchmark NIFTY Healthcare TRI. Broader Benchmark NSE - Nifty 50 TRI
Fund Manager Rohan Korde
 
Riskometer
Investors understand that their principal will be at Very High risk
 
Scheme Objective
The scheme seeks to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare.

Portfolio Classification
 
Asset Mix
 
Concentration Analysis
Top 5 Holdings 36.50%
Top 10 Holdings 55.30%
Top 25 Holdings 84.79%
 
Sector Analysis
Sector/Ratings Net Asset(%)
Pharma & Biotech 69.1
Healthcare 24.03
Fertilisers 2.07
Cash 1.69
Miscellaneous 1.25
Industrial Products 1.05
Chemicals 0.81
 
 
 
 
 
Portfolio Metrics
PB Ratio 5.95
PE Ratio 46.11
 
Top 25 Holdings
Holdings Net Asset(%)
Sun Pharmaceutical Industries Limited 10.96
DIVI LABORATORIES LTD 8.97
Apollo Hospitals Enterprise Limited 6.35
Max Healthcare Institute Limited 5.71
Torrent Pharmaceuticals Limited 4.51
Cohance Lifesciences Limited 4.43
Fortis Health Care Ltd 3.98
Aurobindo Pharma Limited 3.70
Aster DM Healthcare Limited 3.62
Cipla Limited 3.07
Lupin Limited 3.04
Alkem Laboratories Limited 2.95
Neuland Laboratories Limited 2.82
Dr Reddys Laboratories Limited 2.57
Wockhardt Limited 2.27
Abbott India Limited 2.20
Healthcare Global Enterprises Limited 1.77
Glenmark Pharmaceuticals Limited 1.73
Net Receivables / (Payables) 1.69
Laurus Labs Limited 1.69
Sai Life Sciences Limited 1.53
FDC Limited 1.40
Sumitomo Chemical India Limited 1.35
SBI Life Insurance Co Ltd 1.25
IPCA Laboratories Limited 1.23

Performance Analysis
 
Short Terms Returns
1 Month 3 Month 6 Month 1 Year
-1.83% -1.16% -0.43% -7.26%
 
Broader Market Benchmark [NSE - Nifty 50 TRI]
2.70% 6.00% 5.46% 7.43%
 
Scheme Benchmark [NSE - Nifty Healthcare TRI]
1.11% 2.55% 5.69% 3.63%
 
Long term Returns
2 Year 3 Year 5 Year 10 Year
16.58% 18.57% 0.00% 0.00%
 
 
13.19% 13.29% 15.94% 14.28%
 
 
21.00% 22.31% 16.00% 9.51%
 
Cumulative Performance of Last 5 Years
 
Calendar Year Returns

Risk Analysis
 
Absolute Metrics (Single Computation - last 3 years)
Scheme Name Standard Deviation Sharpe Ratio Downside Deviation Downside Probability Sortino Ratio
ITI Pharma and Healthcare Fund Reg (G) 15.64% 0.7787 11.2742% 43.3018 0.1155
 
Benchmark Relative Metrics (Single Computation - last 3 years)
Scheme Name Alpha Beta Treynor Ratio Tracking Error Information Ratio
ITI Pharma and Healthcare Fund Reg (G) 8.2008% 0.0002 0.2066 14.4894 0.4733
 
Back to Selection